Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Maryam Esmaily(Tehran University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Fatemeh Atyabi(Tehran University of Medical Sciences), Afshin Namdar(University of Alberta), Armin Ahmadi(University of Alabama in Huntsville), Mohsen Nabi‐Afjadi(Tarbiat Modares University), Sepideh Ghani(Shahid Beheshti University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Mozhdeh Sojoodi(Harvard University), Shahin Hallaj(Fleet Science Center), Farinaz Malakotikhah(Islamic Azad University of Falavarjan), Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Hadi Hassannia(Mazandaran University of Medical Sciences), Ali Masjedi(Tabriz University of Medical Sciences)
Cited by 94
Related Papers
Unlimited in vitro expansion of adult bi‐potent pancreas progenitors through the Lgr5/R‐spondin axis
|The EMBO Journal|2013|721
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339